These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32311762)

  • 21. SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health.
    Cossarizza A; De Biasi S; Guaraldi G; Girardis M; Mussini C;
    Cytometry A; 2020 Apr; 97(4):340-343. PubMed ID: 32187834
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID-19: The race for a vaccine.
    Lockey E
    J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926902. PubMed ID: 32404020
    [No Abstract]   [Full Text] [Related]  

  • 23. More bricks in the wall against SARS-CoV-2 infection: involvement of γ9δ2 T cells.
    Rijkers G; Vervenne T; van der Pol P
    Cell Mol Immunol; 2020 Jul; 17(7):771-772. PubMed ID: 32467616
    [No Abstract]   [Full Text] [Related]  

  • 24. Atypical lymphocyte morphology in SARS-CoV-2 infection.
    El Jamal SM; Salib C; Stock A; Uriarte-Haparnas NI; Glicksberg BS; Teruya-Feldstein J; Dembitzer FR; Nadkarni GN; Firpo-Betancourt A
    Pathol Res Pract; 2020 Sep; 216(9):153063. PubMed ID: 32825937
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
    Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N
    PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(697):1220-1221. PubMed ID: 32520467
    [No Abstract]   [Full Text] [Related]  

  • 27. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.
    Sacchi A; Grassi G; Bordoni V; Lorenzini P; Cimini E; Casetti R; Tartaglia E; Marchioni L; Petrosillo N; Palmieri F; D'Offizi G; Notari S; Tempestilli M; Capobianchi MR; Nicastri E; Maeurer M; Zumla A; Locatelli F; Antinori A; Ippolito G; Agrati C
    Cell Death Dis; 2020 Oct; 11(10):921. PubMed ID: 33110074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    Persad G; Emanuel EJ
    JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357
    [No Abstract]   [Full Text] [Related]  

  • 29. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.
    Goudsmit J
    Eur J Epidemiol; 2020 Apr; 35(4):331-333. PubMed ID: 32318914
    [No Abstract]   [Full Text] [Related]  

  • 30. Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.
    Bishop MR
    Clin Adv Hematol Oncol; 2020 Jul; 18(7):400-403. PubMed ID: 32903251
    [No Abstract]   [Full Text] [Related]  

  • 31. Airborne Particulate Matter and SARS-CoV-2 Partnership: Virus Hitchhiking, Stabilization and Immune Cell Targeting - A Hypothesis.
    Farhangrazi ZS; Sancini G; Hunter AC; Moghimi SM
    Front Immunol; 2020; 11():579352. PubMed ID: 33072124
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies.
    Zhao M
    Int J Antimicrob Agents; 2020 Jun; 55(6):105982. PubMed ID: 32305588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 and post-traumatic stress disorder: A vicious circle involving immunosuppression.
    Liang X; Zhu Y; Fang Y
    CNS Neurosci Ther; 2020 Aug; 26(8):876-878. PubMed ID: 32678521
    [No Abstract]   [Full Text] [Related]  

  • 34. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia.
    Quinti I; Lougaris V; Milito C; Cinetto F; Pecoraro A; Mezzaroma I; Mastroianni CM; Turriziani O; Bondioni MP; Filippini M; Soresina A; Spadaro G; Agostini C; Carsetti R; Plebani A
    J Allergy Clin Immunol; 2020 Jul; 146(1):211-213.e4. PubMed ID: 32333914
    [No Abstract]   [Full Text] [Related]  

  • 35. Surviving COVID-19: A disease tolerance perspective.
    Ayres JS
    Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
    [No Abstract]   [Full Text] [Related]  

  • 36. All eyes on a hurdle race for a SARS-CoV-2 vaccine.
    Gaebler C; Nussenzweig MC
    Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943
    [No Abstract]   [Full Text] [Related]  

  • 37. Cellular immune responses to covid-19.
    Sewell HF; Agius RM; Stewart M; Kendrick D
    BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversing immunosenescence for prevention of COVID-19.
    Brooke RT; Fahy GM
    Aging (Albany NY); 2020 Jun; 12(12):11161-11162. PubMed ID: 32597792
    [No Abstract]   [Full Text] [Related]  

  • 39. Can the Environmental Phagocyte
    Siddiqui R; Khan NA
    ACS Chem Neurosci; 2020 Aug; 11(15):2149-2151. PubMed ID: 32662981
    [No Abstract]   [Full Text] [Related]  

  • 40. B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020.
    Hurwitz JL
    Viral Immunol; 2020 May; 33(4):251-252. PubMed ID: 32348715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.